Does renal function influence plasma levels of advanced glycation and oxidation protein products in patients with chronic rheumatic diseases complicated by secondary amyloidosis?

Kidney and Blood Pressure Research

Volumn 30, Issue 1, 2007, Pages 1-7

  Ryšavá, Romana ^a   Kalousová, Marta ^a   Zima, Tomáš ^a   Dostál, Ctibor ^a   Merta, Miroslav ^a   Tesař, Vladimír ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Advanced glycation end products; Advanced oxidation protein products; Rheumatoid arthritis; Secondary amyloidosis

Indexed keywords

ADVANCED GLYCATION END PRODUCT; CARBONYL DERIVATIVE; CREATININE; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ADULT; AGED; AMYLOIDOSIS; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DIAGNOSTIC PROCEDURE; FEMALE; GLOMERULUS FILTRATION RATE; GLYCATION; HISTOLOGY; HUMAN; HUMAN TISSUE; KIDNEY CLEARANCE; KIDNEY FAILURE; KIDNEY FUNCTION; MALE; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS;

AGED; AMYLOIDOSIS; BIOLOGICAL MARKERS; CHRONIC DISEASE; COHORT STUDIES; CYTOKINES; FEMALE; GLYCOSYLATION; HUMANS; INFLAMMATION; KIDNEY; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; OXIDATION-REDUCTION; OXIDATIVE STRESS; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; RECEPTORS, IMMUNOLOGIC; RHEUMATIC DISEASES;

EID: 33847046667     PISSN: 14204096     EISSN: None     Source Type: Journal    
DOI: 10.1159/000098140     Document Type: Article

References (22)

1. Kalousová M, Sulková S, Fialová L, Soukupová J, Malbohan IM, Špaček P, Braun M, Mikulíková L, Fořtová M, Hořejší M, Tesař V, Zima T: Glycoxidation and inflammation in chronic haemodialysis patiens. Nephrol Dial Transplant 2003;18:2577-2581.
2. Kalousová M, Zima T, Tesař V, Sulková S, Fialová L: Relationship between advanced glycoxidation end products, inflammatory markers/acute-phase reactants, and some autoantibodies in chronic hemodialysis patients. Kidney Int 2003;63:S62-S64.
3. Schwedler S, Schinzel R, Vaith P, Wanner C: Inflammation and advanced glycation end products in uremia: simple coexistence, potential or casual relationship? Kidney Int 2001;59:S32-S36.
4. Miyata T, Maeda K, Kurokawa K, van Ypersele de Strihou C: Oxidation conspires with glycation to generate noxious advanced glycation end products in renal failure. Nephrol Dial Transplant 1997;12:255-258.
5. Miyata T, Wada Y, Cai Z, Iida Y, Horie K, Yasuda Y, Maeda K, Kurokawa K, van Ypersele de Strihou C: Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure. Kidney Int 1997;51:1170-1181.
6. Witko-Sarsat V, Friedlander M, Capeillere-Blandin Ch, Nguyen-Khoa T, Nguen AT, Zingraff J, Junkers P, Descamps-Latscha B: Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 1996;49:1304-1313.
7. Witko-Sarsat V, Gausson V, Descamps-Latscha B: Are advanced oxidation protein products potential uremic toxins? Kidney Int 2003;84:S11-S14.
8. Bayes-Genis A, Conover CA, Overgaard MT, Bailey KR, Christiansen M, Holmes DR Jr, Virmani R, Oxving C, Schwartz RS: Pregnancy-associated plasma protein A as a marker of acute coronary syndromes. N Engl J Med 2001;345:1022-1029.
9. Khosravi J, Diamandi A, Krishna RG, Bodani U, Mistry J, Khaja N: Pregnancy associated plasma protein-A: ultrasensitive immunoassay determination in coronary heart disease. Clin Biochem 2002;35:531-538.
10. Henle T, Deppisch R, Beck W, Hergessel O, Hansch G, Ritz E: Advanced glycated end-products (AGE) during haemodialysis treatment: discrepant results with different methodologies reflecting the heterogenity of AGE compounds. Nephrol Dial Transplant 1999;14:1968-1975.
11. Munch G, Kies R, Wessel A, Riederer P, Bahner U, Heidland A, Niwa T, Lemke HD, Schinzel R: Determination of advanced glycation end products in serum by fluorescence spectroscopy and competitive ELISA. Eur J Clin Chem Clin Biochem 1997;35:669-677.
12. Ryšavá R, Merta M, Tesař V, Jirsa M, Zima T: Can serum amyloid A or macrophage colony stimulating factor serve as marker of amyloid formation process? Biochem Mol Biol Int 1999;47:845-850.
13. Lange U, Boss B, Teichmann J, Klor HU, Neeck G: Serum amyloid A - an indicator of inflammation in ankylosing spondylitis. Rheumatol Int 2000;19:119-122.
14. Wilkins J, Gallimore JR, Tennent GA, Hawkins PN, Limburg PC, van Rijswijk MH, Moore EG, Pepys MB: Rapid automated enzyme immunoassay of serum amyloid A. Clin Chem 1994;40:1284-1290.
15. Nakayama T, Sonoda S, Urano T, Yamada T, Okada M: Monitoring both serum amyloid A and C-reactive protein as inflammatory markers in infectious diseases. Clin Chem 1993;39:293-297.
16. Miwata H, Yamada T, Okada M, Kudo T, Kimura H, Morishima T: Serum amyloid A protein in acute viral infections. Arch Dis Child 1993;68:210-214.
17. Arend WP, Dayer JM: Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum 1990;33:305-315.
18. Gracie JA, Forsey RJ, Ling Chan W, Gilmour A, Lejny BP, Greer MR, Kennedy K, Carter R, Wei X, Xu D, Field M, Foulis A, Liew FY, McInnes IB: A proinflammatory role for IL-18 in rheumatoid arthritis. J Clin Invest 1999;104:1393-1401.
19. Maury CPJ, Tiitinen S, Laiho K, Karela K, Liljeström M: Raised circulating interleukin-18 levels in reactive AA-amyloidosis. Amyloid 2002;9:141-144.
20. Miyata T, van Ypersele de Strihou C, Kurokawa K, Baynes JW: Alteration in nonenzymatic biochemistry in uremia: origin and significance of 'carbonyl stress' in long-term uremic complication. Kidney Int 1999;55:389-399.
21. Friedlander MA, Wu YC, Schulack JA, Minnier VM, Hricik DE: Influence of dialysis modality on plasma and tissue concentration of pentosidine in patients with end-stage renal disease. Am J Kidney Dis 1995;25:445-451.
22. Miyata T, Ueda Y, Shinzato T, Iida Y, Tanaka S, Kurokawa K, van Ypersele de Strihou C, Maeda K: Accumulation of albumin-linked and free-form pentosidine in circulation of uremic patients with end-stage renal failure: renal implications in the pathophysiology of pentosidine. J Am Soc Nephrol 1996;7:1198-1206.